Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
belgian startups
biotech ipos
boston
boston blog main
boston top stories
business
business sponsored company news
clinical trials
dyne therapeutics
fda
features
free
genetics
globachem
life sciences
metacrine
myotonic dystrophy type 1
national blog main
nonalcoholic steatohepatitis
precision agriculture
precision medicine
rare disease drugs
rare diseases
salk institute
san diego blog main
san diego top stories
ulcerative colitis
What
company
3
×
developing
3
×
genetic
3
×
medicine
million
precision
raised
agriculture
akesogen
alzheimer’s
analysis
applications
approaches
assessing
belgian
biostrand
biotechnology
brings
collaboration
comes
commercializing
continue
crop
cytox
data
disease
disorders
disrupt
drug
dyne
dyne’s
extends
founded
fund
globachem
identifies
include
investment
ipo
koen
Language
unset
Current search:
genetic
×
company
×
developing
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@tech.eu
4 years ago
Belgian startup BioStrand raises €2 million to disrupt genetic data analysis
@venturebeat.com
6 years ago
Cytox in Collaboration with AKESOgen Extends Genetic Test for Assessing Alzheimer’s Risk to Include Saliva Samples